Literature DB >> 28102195

Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.

H Wang1, C Weng2, H Chen1.   

Abstract

Variants in G protein-coupled inward rectifier K+ channels 4 (GIRK4 also known as KCNJ5) gene are associated with primary aldosteronism, which is the most common cause of secondary hypertension. The KCNJ5 rs2604204 variant was shown to be common (minor allele frequency=32.5%) in Chinese patients with essential hypertension (EH). The relationship between KCNJ5 variant and plasma aldosterone (ALD) levels in EH patients has not been reported. We collected 229 patients with newly diagnosed EH without any antihypertensive agents. According to the median standing plasma ALD, high-ALD and control groups were divided. Clinical data and blood samples were collected. KCNJ5 rs2604204 genotype was determined by PCR. The results showed that the levels of triglyceride, uric acid, insulin, insulin resistance (IR) index, renin, angiotensin I (Ang I), angiotensin II (Ang II), cortisol, 24 h mean systolic blood pressure (SBP) and daytime mean SBP were significantly increased in the high-ALD group than those in the control group, as well as 24 h s.d. of SBP and diastolic BP (DBP), and 24 h coefficient of variance of SBP and DBP. Notably, the distribution frequency of AC and CC genotypes, and the C allele of KCNJ5 were also significantly higher in the high-ALD group. Logistic regression analysis showed that the C allele of KCNJ5 rs2604204 was one risk factor for increased plasma ALD in Chinese EH patients (P=0.008, odds ratio=2.2 (95% confidence interval 1.2-4.1)). Our findings indicated that the variation of plasma ALD might be associated with increased IR and BP variability. Moreover, KCNJ5 rs2604204 polymorphism was related to increased plasma ALD level, but also plasma renin, Ang I and II levels in newly diagnosed, never-treated EH patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28102195     DOI: 10.1038/jhh.2016.97

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  33 in total

1.  Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

Authors:  Sheerazed Boulkroun; Felix Beuschlein; Gian-Paolo Rossi; José-Felipe Golib-Dzib; Evelyn Fischer; Laurence Amar; Paolo Mulatero; Benoit Samson-Couterie; Stefanie Hahner; Marcus Quinkler; Francesco Fallo; Claudio Letizia; Bruno Allolio; Giulio Ceolotto; Maria Verena Cicala; Katharina Lang; Hervé Lefebvre; Livia Lenzini; Carmela Maniero; Silvia Monticone; Maelle Perrocheau; Catia Pilon; Pierre-François Plouin; Nada Rayes; Teresa M Seccia; Franco Veglio; Tracy Ann Williams; Laura Zinnamosca; Franco Mantero; Arndt Benecke; Xavier Jeunemaitre; Martin Reincke; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

Review 2.  Aldosteronism and hypertension.

Authors:  David A Calhoun
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-12       Impact factor: 8.237

3.  Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations.

Authors:  Tine W Hansen; Lutgarde Thijs; Yan Li; José Boggia; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2010-03-08       Impact factor: 10.190

4.  Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Andreas Meinitzer; Bernhard O Boehm; Winfried März
Journal:  Eur Heart J       Date:  2010-03-02       Impact factor: 29.983

5.  Aldosterone production and insulin resistance in healthy adults.

Authors:  Rajesh Garg; Shelley Hurwitz; Gordon H Williams; Paul N Hopkins; Gail K Adler
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

6.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  Plasma aldosterone and its relationships with left ventricular mass in essential hypertensive patients with the metabolic syndrome.

Authors:  Giuseppe Mulè; Emilio Nardi; Paola Cusimano; Santina Cottone; Giovanna Seddio; Calogero Geraci; Alessandro Palermo; Giuseppe Andronico; Giovanni Cerasola
Journal:  Am J Hypertens       Date:  2008-06-26       Impact factor: 2.689

8.  Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects.

Authors:  Alfonso Tatasciore; Giulia Renda; Marco Zimarino; Manola Soccio; Grzegorz Bilo; Gianfranco Parati; Giuseppe Schillaci; Raffaele De Caterina
Journal:  Hypertension       Date:  2007-06-11       Impact factor: 10.190

9.  Abnormal aldosterone physiology and cardiometabolic risk factors.

Authors:  Anand Vaidya; Patricia C Underwood; Paul N Hopkins; Xavier Jeunemaitre; Claudio Ferri; Gordon H Williams; Gail K Adler
Journal:  Hypertension       Date:  2013-02-11       Impact factor: 10.190

10.  High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells.

Authors:  Carmen Härdtner; Caroline Mörke; Reinhard Walther; Carmen Wolke; Uwe Lendeckel
Journal:  Int J Mol Med       Date:  2013-08-14       Impact factor: 4.101

View more
  1 in total

Review 1.  Molecular Mechanisms of Primary Aldosteronism.

Authors:  Sergei G Tevosian; Shawna C Fox; Hans K Ghayee
Journal:  Endocrinol Metab (Seoul)       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.